ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential

ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential

On 11 March 2020, the World Health Organization (WHO) classified the Coronavirus Disease 2019 (COVID-19) as a global pandemic, which tested healthcare systems, administrations, and treatment ingenuity across the world. COVID-19 is caused by the novel beta coronavirus Severe Acute Respiratory Syndrom...

Full description

Bibliographic Details
Main Authors:	Subrata Deb, Anthony Allen Reeves, Robert Hopefl, Rebecca Bejusca
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Pharmaceuticals
Subjects:	remdesivir ADME pharmacokinetics COVID-19 cytochrome P450 drug interaction
Online Access:	https://www.mdpi.com/1424-8247/14/7/655

Similar Items

ADME Gene-Related Pharmacogenomic Labeling of FDA-Approved Drugs: Comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) Evidence Levels
by: Subrata Deb, et al.
Published: (2024-02-01)

Pharmacokinetics and Safety of Lurbinectedin Administrated with Itraconazole in Cancer Patients: A Drug–Drug Interaction Study
by: Irene Moreno, et al.
Published: (2024-04-01)

Simulation of Physicochemical and Pharmacokinetic Properties of Vitamin D<sub>3</sub> and Its Natural Derivatives
by: Subrata Deb, et al.
Published: (2020-07-01)

Pharmacokinetic and pharmacodynamic drug-drug interaction of Nomilin with atorvastatin in hyperlipidemic mice
by: Yan Ding, et al.
Published: (2023-11-01)

Evaluation of Pharmacokinetic Drug–Drug Interactions: A Review of the Mechanisms, In Vitro and In Silico Approaches
by: Yaru Peng, et al.
Published: (2021-01-01)

Pharmacokinetic evaluation of the interaction between oral kaempferol and ethanol in rats
by: Zhou Zhaoxiang, et al.
Published: (2016-12-01)

The Development and Validation of a Novel “Dual Cocktail” Probe for Cytochrome P450s and Transporter Functions to Evaluate Pharmacokinetic Drug-Drug and Herb-Drug Interactions
by: Mihwa Kwon, et al.
Published: (2020-09-01)

Effect of chronic unpredicted mild stress-induced depression on clopidogrel pharmacokinetics in rats
by: Xueyao Jiang, et al.
Published: (2022-10-01)

Potential Effects of Ibuprofen, Remdesivir and Omeprazole on Dexamethasone Metabolism in Control Sprague Dawley Male Rat Liver Microsomes (Drugs Often Used Together Alongside COVID-19 Treatment)
by: Amira Hussain, et al.
Published: (2022-03-01)

Ginkgo biloba L.: An Updated Review on the Pharmacological Activities, Pharmacokinetics and Drug Interactions
by: Zahra Moeinipour, et al.
Published: (2024-12-01)

Effect of P. corylifolia on the pharmacokinetic profile of tofacitinib and the underlying mechanism
by: Yu Wang, et al.
Published: (2024-04-01)

Effect of Dexamethasone on Abiraterone Pharmacokinetics in Mice: Determined by LC/MS Analysis
by: Subrata Deb, et al.
Published: (2023-03-01)

INDI: a computational framework for inferring drug interactions and their associated recommendations
by: Assaf Gottlieb, et al.
Published: (2012-07-01)

Cranberry Ingestion Modulated Drug Transporters and Metabolizing Enzymes: Gefitinib Used as a Probe Substrate in Rats
by: Chung-Ping Yu, et al.
Published: (2022-09-01)

Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions
by: Subrata Deb, et al.
Published: (2021-06-01)

Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug–Drug Interactions of Phenytoin
by: Leyanis Rodriguez-Vera, et al.
Published: (2023-10-01)

ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs
by: Tridib Chaira, et al.
Published: (2023-04-01)

The Impact of Baohuoside I on the Metabolism of Tofacitinib in Rats
by: Shi Y, et al.
Published: (2024-03-01)

Metformin represses drug – induced expression of CYP2B6 by the constitutive androstane receptor phosphorylation
Published: (2014-10-01)

Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case report
by: Camilo Scherkl, et al.
Published: (2024-06-01)

Impact of Pomegranate Juice on the Pharmacokinetics of CYP3A4- and CYP2C9-Mediated Drugs Metabolism: A Preclinical and Clinical Review
by: Kenza Mansoor, et al.
Published: (2023-02-01)

Impact of sex on antidepressant discontinuation in groups of similar cytochrome P450 phenotypes
by: Dylan L. Kosaski, PharmD, et al.
Published: (2023-12-01)

The use of active site mutants of cytochrome P450(cam) in chemical synthesis
by: Bell, S, et al.
Published: (1999)

Nicotine Gum in Thai Smokers with Different CYP2A6 Enzymes: A Population Pharmacokinetic Analysis
by: Kathy Moesan, et al.
Published: (2024-08-01)

Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug–Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach
by: Laura Maria Fuhr, et al.
Published: (2021-02-01)

The risk of milk thistle (<i>Silybum marianum</i>) drug interactions
by: A. S. Kazakov, et al.
Published: (2018-02-01)

Integration of Ontogeny-Based Changes for Predicting the Exposure of Diphenhydramine in the Pediatric Population: A PBPK Modeling Approach
by: Ammara Zamir, et al.
Published: (2024-12-01)

Impact of bariatric surgery on cytochrome P 450 enzyme activity
by: Anna Pham, et al.
Published: (2024-03-01)

Combating the causative agent of amoebic keratitis, Acanthamoeba castellanii, using Padina pavonica alcoholic extract: toxicokinetic and molecular docking approaches
by: Sara S. Abdel-Hakeem, et al.
Published: (2024-06-01)

Engineering cytochrome P450s for bioremediation /
by: 242771 Kellner, David G., et al.

Comparison of Anticancer Drug Toxicities: Paradigm Shift in Adverse Effect Profile
by: Debasish Basak, et al.
Published: (2021-12-01)

Induction of hepatic CYP3A4 expression by cholesterol and cholic acid: Alterations of gene expression, microsomal activity, and pharmacokinetics
by: Genki Minegishi, et al.
Published: (2024-06-01)

A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug–Drug Interaction Modeling
by: Laura Maria Fuhr, et al.
Published: (2022-07-01)

A Mechanistic, Enantioselective, Physiologically Based Pharmacokinetic Model of Verapamil and Norverapamil, Built and Evaluated for Drug–Drug Interaction Studies
by: Nina Hanke, et al.
Published: (2020-06-01)

A Physiologically Based Pharmacokinetic Model of Ketoconazole and Its Metabolites as Drug–Drug Interaction Perpetrators
by: Fatima Zahra Marok, et al.
Published: (2023-02-01)

In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin
by: Jan Thomann, et al.
Published: (2024-04-01)

Pharmacokinetics Profile and Genetics of Double Antiviral Therapy with Remdesivir and Nirmatrelvir/Ritonavir for Prolonged COVID-19 in Patients Treated with Rituximab: A Real-Life Study and Literature Review
by: Ilaria De Benedetto, et al.
Published: (2024-01-01)

Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network
by: Fatima Zahra Marok, et al.
Published: (2021-03-01)

Drug–Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain
by: Maria G. Campos, et al.
Published: (2024-05-01)

Isoform CYP1A2, as a part of the cytochrome P450 superfamily
by: Y. G. Novickaya, et al.
Published: (2014-04-01)